Gaoyuan Wang

State Key Laboratory Of Oncology In South China, Guangdong Key Laboratory Of Nasopharyngeal Carcinoma Diagnosis And Therapy, Guangdong 510060, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy". [Radiother Oncol. 190 (2024) 109985].

Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy". [Radiother Oncol. 190 (2024) 109985].

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 17, 2026

Combined Real-time Liquid Biopsy With TNM Stage to Guide Induction Chemotherapy Cycles in Nasopharyngeal Carcinoma: A Development and Validation Study.

Combined Real-time Liquid Biopsy With TNM Stage to Guide Induction Chemotherapy Cycles in Nasopharyngeal Carcinoma: A Development and Validation Study.

Journal: International journal of radiation oncology, biology, physics

Published: October 15, 2025

Dextran based dual-dynamic-network hydrogel for chronic wound healing with mechanically adaptive, antibacterial, and pH-responsive drug delivery.

Dextran based dual-dynamic-network hydrogel for chronic wound healing with mechanically adaptive, antibacterial, and pH-responsive drug delivery.

Journal: International journal of biological macromolecules

Published: March 21, 2025

Domain engineering of dextransucrase and soft nanoconfinement-enhanced biosynthesis of pharmaceutical-grade dextran.

Domain engineering of dextransucrase and soft nanoconfinement-enhanced biosynthesis of pharmaceutical-grade dextran.

Journal: International journal of biological macromolecules

Published: March 01, 2025

Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy" [Radiother. Oncol. 190 (2024) 109985].

Corrigendum to "Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy" [Radiother. Oncol. 190 (2024) 109985].

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 17, 2025

Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040.

Global burdens of nasopharyngeal carcinoma in children and young adults and predictions to 2040.

Journal: Oral oncology

Published: April 21, 2024

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.

Evaluation and analysis of risk factors of hearing impairment for nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 05, 2023

SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.

SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.

Journal: Cancer letters

Published: November 27, 2017

Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers.

Exome sequencing reveals the genetic landscape and frequent inactivation of PCDHB3 in Chinese rectal cancers.

Journal: The Journal of pathology

Published: August 16, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026